Clinical Study of Pabolizumab for Neoadjuvant Immunotherapy of Locally Advanced Microsatellite-unstable Gastric Adenocarcinoma

NCT05816863 · clinicaltrials.gov ↗

UNKNOWN

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer
Gastric Adenocarcinoma

Interventions

DRUG: pabolizumab

Sponsor

Peking University Cancer Hospital & Institute